China (Mainland)
Assessedsupplier 
4H-1-Benzopyran-4-one,5,6,7-trihydroxy-2-phenyl- CAS NO.491-67-8
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,Other
- Product Details
Keywords
- 4H-1-Benzopyran-4-one,5,6,7-trihydroxy-2-phenyl-? price
- 4H-1-Benzopyran-4-one,5,6,7-trihydroxy-2-phenyl-? CAS 491-67-8
- 4H-1-Benzopyran-4-one,5,6,7-trihydroxy-2-phenyl-? supplier in China
Quick Details
- ProName: 4H-1-Benzopyran-4-one,5,6,7-trihydroxy...
- CasNo: 491-67-8
- Molecular Formula: C15H10O5?
- Appearance: yellow crystalline solid
- Application: An inhibitor of 12-lipoxygenase, leuko...
- DeliveryTime: 15 days after order confirmed
- PackAge: 1kg/bag, 1kg/drum or 25kg/drum or as p...
- Port: Shanghai, Ningbo, Tianjin, etc
- ProductionCapacity: 1 Metric Ton/Month
- Purity: 99%
- Storage: Stored in cool, dry and ventilation pl...
- Transportation: as per your request
- LimitNum: 1 Kilogram
Superiority
superior quality
Details
| Baicalein Chemical Properties |
| mp | 256-271 °C(lit.) |
| storage temp. | 2-8°C |
| Merck | 14,942 |
| BRN | 272683 |
| CAS DataBase Reference | 491-67-8(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | Xi,Xn |
| Risk Statements | 36/37/38-20/21/22 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| Hazard Note | Irritant |
| MSDS Information |
| Provider | Language |
|---|---|
| SigmaAldrich | English |
| ALFA | English |
| Baicalein Usage And Synthesis |
| Chemical Properties | Yellow Crystalline Solid |
| Usage | antiviral (HIV) |
| Usage | An inhibitor of 12-lipoxygenase, leukotriene biosynthesis and release of lysosomal enzymes. It also inhibits cellular Ca2+ uptake and mobilization and adjuvant-induced arthritis. Baicalein is the fl avonoid component of Nepalese and Sino-Japanese crude drugs. |
| Usage | inhibitor of lipoxidase and leukotriene biosynthesis |
| Biological Activity | Inhibitor of 5- and platelet 12-lipoxygenases (IC 50 values are 9.5 and 0.12 mM respectively). Also inhibits Raf-mediated MEK-1 phosphorylation in C6 rat glioma cells and induces G1 and G2 cell cycle arrest by decreasing cdk1, cdk2, cyclin D2 and cyclin A expression. Anti-inflammatory in vivo . |